FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

BPC-157 + TB-500 — Published Research

Reviewed by: Dr. Sarah Chen, PharmD| Last updated: abril 9, 2026|For laboratory reference only

← Back to BPC-157 + TB-500 product page

Ver reportes de laboratorio · Calidad y pruebas · Preguntas frecuentes

Biblioteca de investigación

Published research on these compounds — for educational purposes only

BPC-157 Nitric Oxide System Interactions

BPC-157 has been investigated for its interactions with the nitric oxide (NO) system in multiple animal models. In vitro studies demonstrate that BPC-157 modulates NO synthase (NOS) expression and NO release in endothelial cells. The peptide’s effects on the NO pathway have been characterized in both L-NAME (NOS inhibitor) and L-arginine (NOS substrate) co-administration models, suggesting a modulatory rather than unidirectional mechanism on NO signaling.

Sikiric P et al. “Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications.” Curr Neuropharmacol. 2016. PubMed

BPC-157 Tendon Fibroblast and Growth Factor Research

In vitro studies using rat Achilles tendon fibroblasts demonstrated that BPC-157 modulates growth hormone receptor (GHR) expression in a time-dependent manner. At concentrations of 1–100 ng/mL, the peptide altered GHR mRNA levels and downstream signaling through JAK2/STAT pathways. Separate studies in tendon explant models showed BPC-157 influenced type I collagen expression and tendon fibroblast migration rates.

Chang CH et al. “Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts.” Molecules. 2014. PubMed

Thymosin Beta-4 Actin-Binding and Cell Migration

Thymosin beta-4 (Tβ4) is a 43-amino-acid peptide that sequesters G-actin monomers, regulating actin polymerization dynamics. The active domain (residues 17–23, LKKTETQ) has been identified as critical for actin binding. TB-500 contains this active sequence. Research in dermal fibroblast and keratinocyte models demonstrated that Tβ4 modulates cell migration through Rac1/Cdc42 GTPase signaling and upregulates matrix metalloproteinases involved in extracellular matrix remodeling.

Malinda KM et al. “Thymosin beta4 accelerates wound healing.” J Invest Dermatol. 1999. PubMed

Thymosin Beta-4 Angiogenesis Signaling Pathways

Research in endothelial cell models has characterized Tβ4’s role in angiogenesis signaling. Studies using human umbilical vein endothelial cells (HUVECs) showed that Tβ4 activates the Akt/eNOS pathway, increasing nitric oxide production and endothelial tube formation. Matrigel plug assays in murine models demonstrated that Tβ4 administration influenced vascularization parameters. The mechanism involves interaction with PINCH-1 and integrin-linked kinase (ILK) signaling complexes.

Smart N et al. “Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.” Nature. 2007. PubMed

Disclaimer: All research citations are provided as references to published laboratory literature only. These materials may summarize in vitro and animal-model findings. Products are sold strictly for laboratory research use. No statements on this page are intended as dosing, administration, treatment, or other human-use guidance.

Reviewed by

Dr. Sarah Chen, PharmD

Research pharmacologist specializing in peptide chemistry and literature analysis. Reviews analytical, in vitro, and preclinical research for accuracy and completeness.

Editorial Review

Reviewed by Dr. Sarah Chen, PharmD y Dr. James Porter, PhD — Panda Peptides Research Team.

Last reviewed: April 2026.

This content summarizes published laboratory literature for research-reference purposes only. Products referenced by Panda Peptides are sold strictly for laboratory research use. This page is not intended as dosing, administration, treatment, or other human-use guidance.